Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced companies to merge:

This article was originally published in Clinica

Executive Summary

Advanced NMR Systems will take over the remaining 39% of Advanced Mammography Systems. Advanced Mammography shareholders will receive $2.63 worth in Advanced NMR stock for each Advanced Mammography share. Jack Nelson, chairman and CEO of both companies believes cost savings will be achieved as a result of sharing certain administrative expenses. Advanced Mammography will operate as a wholly-owned subsidiary of Advanced NMR on completion of the merger. Advanced NMR already owns 61% of Advanced Mammography common stock.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT087228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel